Rite Aid Corporation
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Elizabeth H. Burr
- Full Time Employees
- 47,000
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- Address
- 1200 Intrepid Avenue Philadelphia PA United States of America
- IPO Date
- Mar 17, 1980
- CIK
- 0000084129
- Website
- riteaid.com
- Similar Companies
- Business
- Rite Aid Corporation operates as a retail drugstore chain primarily in the United States, offering a wide range of products and services including prescription medications, over-the-counter health and wellness products, beauty and personal care items, household goods, food and beverages, and seasonal merchandise. The company also provides healthcare services through its retail pharmacies and affiliated clinics, including immunizations, health screenings, and chronic condition management. Historically, Rite Aid engaged in pharmacy benefit management (PBM) services through its subsidiary Elixir, which it sold in January 2024. Founded in 1962 and headquartered in Camp Hill, Pennsylvania, Rite Aid operates approximately 1,240 stores across 15 states as of 2025. The company targets individual consumers needing pharmacy and health-related products as well as healthcare services, positioning itself as a community-focused health and wellness provider. In recent years, Rite Aid has faced significant financial challenges. It filed for Chapter 11 bankruptcy twice: first in October 2023 and again in May 2025, citing a heavy debt load, competitive pressures, and operational difficulties. Following the second bankruptcy filing, Rite Aid announced the sale of all its remaining assets and the closure of its remaining stores by September 2025. The company secured nearly $1.95 billion in new debtor-in-possession financing to facilitate this transition. In the process, Rite Aid sold or transferred parts of its assets, including customer prescription records, to competitors such as CVS, Walgreens, Albertsons, Kroger, and Giant Eagle. Rite Aid's strategic focus had also included a past acquisition of the Bartell Drugs chain in 2020 and efforts to modernize its stores and branding under strategies like "RxEvolution" before its decline. Thus, Rite Aid’s core business historically encompassed retail pharmacy operations with a broad omnichannel product assortment and healthcare services, with recent major changes including the exit from PBM services, repeated bankruptcies, divestiture of assets, and complete wind-down of its retail footprint in 2025 as part of its financial restructuring and liquidation process.
AITX's RAD Announces Additional Healthcare and Construction Orders as Customers Expand Deployments
RAD Amplify Appoints John King as Senior Vice President, Head of Marketing
Recludix Pharma to Present Preclinical Asthma and Dermatitis Data for Oral STAT6 Inhibitor REX-8756 at the European Association of Allergy and Clinical Immunology (EAACI) and Revolutionizing Atopic Dermatitis (RAD) Congresses
Rite Aid closing 114 more stores across multiple states
Rite Aid Prepares to Sell Remaining Assets
Home Decor Retailer Expected To File For Bankruptcy: Report
Unlike CVS, Walgreens Only Interested In Rite Aid Patient Files
Rite Aid Closing Stores and Selling Pharmacy Assets to Rivals
Rite Aid sells 1K pharmacies to rivals — including CVS, Walgreens — after second bankruptcy filing
Rite Aid To Sell Pharmacy Assets From More Than 1,000 Stores To CVS, Walgreens And Grocers
Rite Aid Attributes Bankruptcy Return to Empty Shelves, Shopper Trade-Down
Rite Aid Files for Bankruptcy, Job Cuts Expected
Rite Aid heading for bankruptcy again, plans to cut jobs: report
Rite Aid Emerges From Bankruptcy, Names CFO Matt Schroeder as CEO
Rite Aid Picks Insider CEO As Company Emerges From Bankruptcy
Rite Aid to close over two dozen stores amid bankruptcy proceedings
AITX CEO, Steve Reinharz, Sets Forth the Company’s Path to
AITX’s RAD Penetrates Further into Healthcare Market with
Unprecedented Showcasing: AITX's RAD Sets Sights on ISC West with Featured Presentations and Exposure
RADDOG, the Robot Dog from AITX’s RAD, Continues its Media